LPL Financial’s Prothena Corp PRTA Stock Holding History

LPL Financial’s Portfolio PRTA Stock Details PRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-5,734	Closed	-$210K	–	3268
2018 Q1	$210K	Buy	+5,734	New	+$209K	﹤0.01%	2923

Other funds holding PRTA

WIM

Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

LPL Financial's PRTA Position: Q2 2018 in Review

LPL Financial sold out of Prothena Corp (PRTA) in Q2 2018, closing a stake of 5,734 shares — an estimated $210K sold.

LPL Financial first reported a position in PRTA in Q1 2018 and held it in 1 quarter. The position peaked at $210K in Q1 2018. 125 funds tracked by Wall St. Rank hold PRTA as of Q2 2018.

LPL Financial reported no remaining Prothena Corp position as of Q2 2018 after selling out during the quarter.
LPL Financial sold 5,734 Prothena Corp shares in Q2 2018, an estimated $210K.
LPL Financial first reported a position in Prothena Corp in Q1 2018 and held it in 1 quarter.
LPL Financial's Prothena Corp position peaked at $210K in Q1 2018.
125 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2018.

Based on LPL Financial's 13F filing for Q2 2018, filed 14 Aug 2018.